|
|
||||||||
Clinical Chemistry, Vol 33, 319-327, Copyright © 1987 by American Association for Clinical Chemistry
DH Catlin, RC Kammerer, CK Hatton, MH Sekera and JL Merdink
The equipment, methods, logistics, and results of doping-control analyses for the 1984 Los Angeles Olympic Games are discussed in this article. Within 15 days, 1510 different urine specimens underwent 9440 screening analyses by a combination of gas chromatography, gas chromatography-mass spectrometry, "high-performance" liquid chromatography, and radioimmunoassay. These tests covered more than 200 different drugs and metabolites, including psychomotor stimulants, sympathomimetic amines, central nervous system stimulants, narcotic analgesics, and anabolic steroids. The results are summarized by class of drug. Less than 2% of the samples were found to contain a banned drug.
The following articles in journals at HighWire Press have cited this article:
![]() |
C. Wang, D. H. Catlin, B. Starcevic, D. Heber, C. Ambler, N. Berman, G. Lucas, A. Leung, K. Schramm, P. W. N. Lee, et al. Low-Fat High-Fiber Diet Decreased Serum and Urine Androgens in Men J. Clin. Endocrinol. Metab., June 1, 2005; 90(6): 3550 - 3559. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Aguilera, C. K. Hatton, and D. H. Catlin Detection of Epitestosterone Doping by Isotope Ratio Mass Spectrometry Clin. Chem., April 1, 2002; 48(4): 629 - 636. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Z. Leder, D. H. Catlin, C. Longcope, B. Ahrens, D. A. Schoenfeld, and J. S. Finkelstein Metabolism of Orally Administered Androstenedione in Young Men J. Clin. Endocrinol. Metab., August 1, 2001; 86(8): 3654 - 3658. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Aguilera, T. E. Chapman, B. Starcevic, C. K. Hatton, and D. H. Catlin Performance Characteristics of a Carbon Isotope Ratio Method for Detecting Doping with Testosterone Based on Urine Diols: Controls and Athletes with Elevated Testosterone/Epitestosterone Ratios Clin. Chem., February 1, 2001; 47(2): 292 - 300. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. H. Catlin, B. Z. Leder, B. Ahrens, B. Starcevic, C. K. Hatton, G. A. Green, and J. S. Finkelstein Trace Contamination of Over-the-Counter Androstenedione and Positive Urine Test Results for a Nandrolone Metabolite JAMA, November 22, 2000; 284(20): 2618 - 2621. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. G. Pope Jr, E. M. Kouri, and J. I. Hudson Effects of Supraphysiologic Doses of Testosterone on Mood and Aggression in Normal Men: A Randomized Controlled Trial Arch Gen Psychiatry, February 1, 2000; 57(2): 133 - 140. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Strawford, T. Barbieri, M. Van Loan, E. Parks, D. Catlin, N. Barton, R. Neese, M. Christiansen, J. King, and M. K. Hellerstein Resistance Exercise and Supraphysiologic Androgen Therapy in Eugonadal Men With HIV-Related Weight Loss: A Randomized Controlled Trial JAMA, April 14, 1999; 281(14): 1282 - 1290. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. MacAuley Fortnightly Review: Drugs in sport BMJ, July 27, 1996; 313(7051): 211 - 215. [Full Text] |
||||
![]() |
D. H. Catlin and T. H. Murray Performance-Enhancing Drugs, Fair Competition, and Olympic Sport JAMA, July 17, 1996; 276(3): 231 - 237. [Abstract] [PDF] |
||||
![]() |
H. G. Pope Jr and D. L. Katz Psychiatric and Medical Effects of Anabolic-Androgenic Steroid Use: A Controlled Study of 160 Athletes Arch Gen Psychiatry, May 1, 1994; 51(5): 375 - 382. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |